PTK2 and colorectal carcinoma: Meanwhile, we demonstrated that SULF1 could negatively regulate ARSH through the FAK/PI3K/AKT/mTOR pathway.<h4>Conclusion</h4>We demonstrated that SULF1 could promote CRC progression by regulating ARSH.